Free Trial

Amplifon (OTCMKTS:AMFPF) Shares Gap Up - What's Next?

Amplifon logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped up premarket from $10.49 to an $11.68 open and last traded at $11.92 on very light volume (~200 shares), signaling a sharp short-term move.
  • Analyst sentiment is mixed: Jefferies recently cut the stock to a hold, and overall ratings are split (two Buys, two Holds) with an average designation of Moderate Buy.
  • Key fundamentals and technicals show a $2.62B market cap, P/E of 21.29, low liquidity ratios (quick 0.54, current 0.62), debt/equity 1.14, and a 50-day moving average ($11.62) below the 200-day ($14.72), suggesting longer-term weakness despite the short-term gap.
  • Five stocks to consider instead of Amplifon.

Shares of Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $10.49, but opened at $11.68. Amplifon shares last traded at $11.92, with a volume of 200 shares.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on AMFPF shares. Jefferies Financial Group cut shares of Amplifon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 18th. Zacks Research raised shares of Amplifon to a "hold" rating in a research note on Tuesday, April 28th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy".

Check Out Our Latest Analysis on AMFPF

Amplifon Stock Performance

The company has a market cap of $2.62 billion, a P/E ratio of 21.29 and a beta of 0.63. The company has a quick ratio of 0.54, a current ratio of 0.62 and a debt-to-equity ratio of 1.14. The stock has a 50 day moving average price of $11.62 and a two-hundred day moving average price of $14.72.

Amplifon Company Profile

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines